Upgrade to SI Premium - Free Trial

Barclays Starts Cellectis (CLLS) at Overweight

May 28, 2026 3:36 AM
(Updated - May 28, 2026 3:43 AM EDT)

Barclays analyst Lukas Shumway initiates coverage on Cellectis (NASDAQ: CLLS) with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage